Data / Form D filings / LungLife AI, Inc.
LungLife AI, Inc.: Form D filings
LungLife AI, Inc., a biotechnology company in Thousand Oaks, CA, filed 46 Form D notices with the SEC between 2009 and 2024. The latest, on March 22, 2024, reports $315,780 sold of a $315,780 offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2545 W. HILLCREST DRIVE, SUITE 140, Thousand Oaks, CA, 91320
- Phone
- (805) 409-9868
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1445789
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | New notice | $315,780 | $315,780 | 8 | Mar 22, 2024 | sec.gov | |
| Jul 16, 2021 | New notice | $6,076,213 | $6,076,213 | 1 | Jul 8, 2021 | sec.gov | |
| Jul 16, 2021 | New notice | $1,083,905 | $1,083,905 | 2 | Jul 8, 2021 | sec.gov | |
| Jul 15, 2021 | New notice | $2,844,999 | $2,844,999 | 2 | Jul 7, 2021 | sec.gov | |
| May 26, 2021 | Amendment | $12,332,080 | $10,246,366 | $2,085,714 | 35 | Oct 26, 2017 | sec.gov |
| Dec 7, 2020 | New notice | $90,000 | $90,000 | 1 | Dec 1, 2020 | sec.gov | |
| Mar 19, 2020 | Amendment | $10,332,080 | $7,844,124 | $2,487,956 | 35 | Oct 26, 2017 | sec.gov |
| Oct 29, 2019 | Amendment | $7,500,000 | $6,564,711 | $935,289 | 35 | Oct 26, 2017 | sec.gov |
| Sep 5, 2019 | Amendment | $7,500,000 | $5,717,163 | $1,782,837 | 35 | Oct 26, 2017 | sec.gov |
| Apr 1, 2019 | Amendment | $6,000,000 | $4,300,207 | $1,699,793 | 2 | Oct 26, 2017 | sec.gov |
| Jan 18, 2019 | Amendment | $6,000,000 | $3,800,207 | $2,199,793 | 5 | Oct 26, 2017 | sec.gov |
| Jan 17, 2019 | Amendment | $3,631,648 | $3,631,648 | 15 | Oct 26, 2017 | sec.gov | |
| Nov 13, 2017 | Amendment | $3,000,000 | $2,173,752 | $826,248 | 3 | Oct 26, 2017 | sec.gov |
| Oct 31, 2017 | New notice | $3,000,000 | $1,756,081 | $1,243,919 | 29 | Oct 26, 2017 | sec.gov |
| Jun 4, 2015 | New notice | $25,426,258 | $25,426,258 | 41 | May 20, 2015 | sec.gov | |
| Sep 2, 2014 | Amendment | $3,000,000 | $3,000,000 | 23 | Jul 10, 2014 | sec.gov | |
| Jul 29, 2014 | Amendment | $3,000,000 | $2,000,000 | $1,000,000 | 2 | Jul 10, 2014 | sec.gov |
| Jul 15, 2014 | New notice | $3,000,000 | $1,782,845 | $1,217,155 | 29 | Jul 10, 2014 | sec.gov |
| Jan 28, 2014 | Amendment | $2,800,000 | $1,482,979 | $1,317,021 | 3 | Nov 21, 2013 | sec.gov |
| Dec 4, 2013 | New notice | $2,800,000 | $1,429,789 | $1,370,211 | 17 | Nov 21, 2013 | sec.gov |
| Nov 25, 2013 | New notice | $3,284,704 | $3,284,704 | 25 | Nov 12, 2013 | sec.gov | |
| Oct 18, 2013 | Amendment | $4,000,000 | $3,202,814 | $797,186 | 2 | Jun 28, 2013 | sec.gov |
| Oct 9, 2013 | Amendment | $4,000,000 | $2,552,814 | $1,447,186 | 1 | Jun 28, 2013 | sec.gov |
| Oct 8, 2013 | Amendment | $4,000,000 | $2,352,814 | $1,647,186 | 2 | Jun 28, 2013 | sec.gov |
| Aug 8, 2013 | Amendment | $4,000,000 | $1,952,814 | $2,047,186 | 5 | Jun 28, 2013 | sec.gov |
| Jul 12, 2013 | New notice | $4,000,000 | $1,756,069 | $2,243,931 | 21 | Jun 28, 2013 | sec.gov |
| Nov 26, 2012 | Amendment | $3,000,000 | $2,992,665 | $7,335 | 15 | Jun 29, 2012 | sec.gov |
| Nov 8, 2012 | Amendment | $3,000,000 | $2,204,802 | $795,198 | 7 | Jun 29, 2012 | sec.gov |
| Aug 1, 2012 | Amendment | $3,000,000 | $2,000,000 | $1,000,000 | 3 | Jun 29, 2012 | sec.gov |
| Jul 25, 2012 | New notice | $3,000,000 | $1,240,780 | $1,759,220 | 22 | Jun 29, 2012 | sec.gov |
| May 7, 2012 | Amendment | $2,650,000 | $2,650,000 | 25 | Nov 4, 2011 | sec.gov | |
| Dec 5, 2011 | Amendment | $2,000,000 | $1,220,000 | $780,000 | 12 | Nov 4, 2011 | sec.gov |
| Nov 29, 2011 | New notice | $2,000,000 | $500,000 | $1,500,000 | 1 | Nov 4, 2011 | sec.gov |
| Nov 29, 2011 | New notice | $1,966,802 | $1,966,802 | 16 | Nov 17, 2011 | sec.gov | |
| May 24, 2011 | Amendment | $2,500,000 | $1,866,334 | $633,666 | 3 | Aug 3, 2010 | sec.gov |
| May 24, 2011 | Amendment | $2,500,000 | $1,605,334 | $894,666 | 1 | Aug 3, 2010 | sec.gov |
| Nov 2, 2010 | Amendment | $2,500,000 | $1,105,334 | $1,394,666 | 4 | Aug 3, 2010 | sec.gov |
| Aug 30, 2010 | Amendment | $2,500,000 | $480,406 | $2,019,594 | 4 | Aug 3, 2010 | sec.gov |
| Aug 11, 2010 | New notice | $2,500,000 | $360,000 | $2,140,000 | 6 | Aug 3, 2010 | sec.gov |
| Jan 11, 2010 | New notice | $2,212,630 | $1,968,783 | $243,847 | 1 | May 20, 2009 | sec.gov |
| Dec 17, 2009 | Amendment | $2,212,630 | $1,718,783 | $493,847 | 2 | May 20, 2009 | sec.gov |
| Nov 24, 2009 | Amendment | $1,668,783 | $1,668,783 | 5 | May 20, 2009 | sec.gov | |
| Nov 12, 2009 | Amendment | $1,667,050 | $1,498,783 | $168,267 | 4 | May 20, 2009 | sec.gov |
| Sep 29, 2009 | Amendment | $1,667,050 | $1,303,783 | $363,267 | 4 | May 20, 2009 | sec.gov |
| Aug 12, 2009 | Amendment | $1,667,050 | $1,184,641 | $482,409 | 5 | May 20, 2009 | sec.gov |
| Jun 4, 2009 | New notice | $1,667,050 | $1,024,485 | $642,565 | 8 | May 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sara Barrington | Director | |
| Andrew Boteler | Director | |
| James McCullough | Director | |
| Paul Pagano | Executive Officer, Director | |
| David Anderson | Executive Officer, Director | |
| Roy Davis | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LungLife AI, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.